Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Saturday, December 9, 2023.
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)
Bull Market Weakness (+75) - XERS is showing signs of short-term weakness, but still remains in the confines of a long-term uptrend. Keep an eye on XERS as it may be in the beginning stages of a reversal.
Is it time to buy, sell, or avoid XERS?
MarketClub looks at technical strength and momentum to determine if the timing is right for XERS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for XERS
The long-term trend has been DOWN since Aug 14th, 2023 at 2.200
The intermediate-term trend has been UP since Dec 8th, 2023 at 1.990
The short-term trend has been UP since Nov 16th, 2023 at 1.718
Smart Scan Analysis for XERS
Based on our trend formula, XERS is rated as a +70 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 1.940 | 2.050 | 1.910 | 2.035 | +0.095 |
| Prev. Close | Volume | Bid | Ask | Time |
| 2.030 | 720961 | 2023-12-08 15:59:10 |
| Year High | 27.9826 | Year High Date | 2018-09-12 |
| Year Low | 15.75 | Year Low Date | 2018-06-21 |
| 52wk High | 3.07 | 52wk High Date | 2023-06-21 |
| 52wk Low | 0.9701 | 52wk Low Date | 2023-01-05 |
| Average Volume | 1,798,626 | Shares Outstanding | 138,125 |
| Market Cap | 275M | Assets | 328,778,000M |
| Liabilities | 315,137,000M | P/E Ratio | -4.52630000 |
| Volatility | 56.41 |